0001789774-19-000001.txt : 20190930 0001789774-19-000001.hdr.sgml : 20190930 20190930161323 ACCESSION NUMBER: 0001789774-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190930 DATE AS OF CHANGE: 20190930 EFFECTIVENESS DATE: 20190930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EnBiotix, Inc. CENTRAL INDEX KEY: 0001789774 IRS NUMBER: 273229277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-350006 FILM NUMBER: 191126222 BUSINESS ADDRESS: STREET 1: 197 W SPRINGFIELD STREET CITY: BOSTON STATE: MA ZIP: 02118 BUSINESS PHONE: 508-400-1856 MAIL ADDRESS: STREET 1: 197 W SPRINGFIELD STREET CITY: BOSTON STATE: MA ZIP: 02118 D 1 primary_doc.xml X0708 D LIVE 0001789774 EnBiotix, Inc. 197 W SPRINGFIELD STREET BOSTON MA MASSACHUSETTS 02118 508-400-1856 DELAWARE Anagenix Therapeutics, Inc. None Corporation true Jeffrey D. Wager 197 W Springfield Street Boston MA MASSACHUSETTS 02118 Executive Officer Director Dennis Ausiello 197 W Springfield Street Boston MA MASSACHUSETTS 02118 Director Roberto Guttmann 197 W Springfield Street Boston MA MASSACHUSETTS 02118 Director Daniel Hartman 197 W Springfield Street Boston MA MASSACHUSETTS 02118 Director Pharmaceuticals Decline to Disclose 06b false 2019-08-21 false true false 0 26000000 3148176 22851824 false 3 0 0 0 false EnBiotix, Inc. /s/Jeffrey D. Wager, M.D. Jeffrey D. Wager, M.D. President 2019-09-26